Safety and efficacy of the nMARQ catheter for paroxysmal and persistent atrial fibrillation | Zendy

Martin Vurma | Zendy; Lam Dang | Zendy; HansPeter BrunnerLa Rocca | Zendy; Gabor Sütsch | Zendy; Christine Attenhofer-Jost | Zendy; Fırat Duru | Zendy; Christoph Scharf | Zendy

AI Assistant Blog Pricing

Open Access

Safety and efficacy of the nMARQ catheter for paroxysmal and persistent atrial fibrillation

Author(s) -

Martin Vurma,

Lam Dang,

HansPeter BrunnerLa Rocca,

Gabor Sütsch,

Christine Attenhofer-Jost,

Fırat Duru,

Christoph Scharf

Publication year - 2016

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/euw048

Subject(s) - medicine , catheter ablation , atrial fibrillation , paroxysmal atrial fibrillation , catheter , cardiology , prospective cohort study , surgery

Circular irrigated radiofrequency ablation using the nMARQ catheter has recently been introduced for the treatment of atrial fibrillation (AF). The aim of this study is to report the safety and efficacy of catheter ablation using this technology in patients with paroxysmal and persistent AF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog